Lotte Biologics, Ottimo Pharma expand antibody manufacturing partnership

Lotte Biologics said Monday it signed a contract manufacturing agreement with UK biotech firm Ottimo Pharma for antibody drugs, expanding the two companies' existing partnership. Under the agreement, Lotte Biologics will produce the active pharmaceutical ingredient for Jankistomig, Ottimo Pharma’s biparatopic antibody candidate, at its Syracuse Bio Campus in New York. The deal builds on an antibody development agreement signed in June last year and reflects Ottimo Pharma’s continued confidence i

By The Korea Herald